Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Capital Expenditures (2020 - 2025)

Trulieve Cannabis has reported Capital Expenditures over the past 6 years, most recently at $2.3 million for Q3 2025.

  • Quarterly results put Capital Expenditures at $2.3 million for Q3 2025, down 96.92% from a year ago — trailing twelve months through Dec 2025 was $3.7 million (down 96.97% YoY), and the annual figure for FY2025 was $3.7 million, down 96.97%.
  • Capital Expenditures for Q3 2025 was $2.3 million at Trulieve Cannabis, up from -$1.4 million in the prior quarter.
  • Over the last five years, Capital Expenditures for TCNNF hit a ceiling of $189.0 million in Q3 2021 and a floor of -$187.2 million in Q4 2021.
  • Median Capital Expenditures over the past 5 years was $2.9 million (2025), compared with a mean of $9.4 million.
  • Biggest five-year swings in Capital Expenditures: tumbled 14611.25% in 2021 and later surged 1581.12% in 2023.
  • Trulieve Cannabis' Capital Expenditures stood at -$187.2 million in 2021, then surged by 101.03% to $1.9 million in 2022, then surged by 1581.12% to $32.5 million in 2023, then soared by 31.4% to $42.7 million in 2024, then tumbled by 94.69% to $2.3 million in 2025.
  • The last three reported values for Capital Expenditures were $2.3 million (Q3 2025), -$1.4 million (Q2 2025), and $2.9 million (Q1 2025) per Business Quant data.